ATE42037T1 - Porphyrine und krebsbehandlung. - Google Patents

Porphyrine und krebsbehandlung.

Info

Publication number
ATE42037T1
ATE42037T1 AT85308444T AT85308444T ATE42037T1 AT E42037 T1 ATE42037 T1 AT E42037T1 AT 85308444 T AT85308444 T AT 85308444T AT 85308444 T AT85308444 T AT 85308444T AT E42037 T1 ATE42037 T1 AT E42037T1
Authority
AT
Austria
Prior art keywords
porphyrins
meso
same
cancer treatment
compound
Prior art date
Application number
AT85308444T
Other languages
English (en)
Inventor
Raymond Prof Bonnett
Morris Cyril Dr Berenbaum
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Application granted granted Critical
Publication of ATE42037T1 publication Critical patent/ATE42037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT85308444T 1984-11-26 1985-11-20 Porphyrine und krebsbehandlung. ATE42037T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848429845A GB8429845D0 (en) 1984-11-26 1984-11-26 Porphyrins & cancer treatment
EP85308444A EP0186962B1 (de) 1984-11-26 1985-11-20 Porphyrine und Krebsbehandlung

Publications (1)

Publication Number Publication Date
ATE42037T1 true ATE42037T1 (de) 1989-04-15

Family

ID=10570288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85308444T ATE42037T1 (de) 1984-11-26 1985-11-20 Porphyrine und krebsbehandlung.

Country Status (11)

Country Link
US (1) US4837221A (de)
EP (1) EP0186962B1 (de)
JP (1) JPH0653665B2 (de)
AT (1) ATE42037T1 (de)
AU (1) AU578329B2 (de)
CA (1) CA1257202A (de)
DE (1) DE3569332D1 (de)
GB (1) GB8429845D0 (de)
HK (1) HK132493A (de)
IE (1) IE58500B1 (de)
ZA (1) ZA858986B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH01242584A (ja) * 1988-03-24 1989-09-27 Yoshio Imai 芳香族ジアミン
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
WO1996009053A1 (en) * 1994-09-20 1996-03-28 Duke University Oxidoreductase activity of manganic porphyrins
ES2249784T3 (es) * 1995-06-07 2006-04-01 Duke University Antioxidantges de oxidantes.
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
DE69928655T2 (de) 1998-04-24 2006-08-24 Duke University Substituierte porphyrine
AU765509B2 (en) * 1998-08-28 2003-09-18 Destiny Pharma Limited Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
ATE552260T1 (de) 1999-01-25 2012-04-15 Nat Jewish Health Substituierte porphyrine und deren therapeutische verwendung
GB0001455D0 (en) 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
JP2004501923A (ja) * 2000-06-26 2004-01-22 カタリスト　　バイオメディカ　リミテッド 発色団の改善及び発色団に関する改善
KR100390771B1 (ko) * 2000-08-31 2003-07-10 한국화학연구원 광역학 치료(ｐｄｔ)용 광민감성 물질로 유용한 포르피린유도체
US20030050297A1 (en) 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
JP5608644B2 (ja) 2008-05-23 2014-10-15 ナショナル ジューイッシュ ヘルス アルキル化種の被爆に関連する損傷の処置方法
EP2230242B1 (de) 2009-03-16 2013-08-14 Johannes Kepler Universität Synthese von neuen asymmetrisch mesosubstituierten wasserlöslichen, als zytostatische Mittel wirkenden Porphyrinen
WO2011161065A1 (en) 2010-06-25 2011-12-29 Fundação Padre Antonio Vieira Macrocyclic tetrapyrrolic compound of the family of porphyrins, chlorins and bacteriochlorins as photosensitizers for photodynamic therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988436A (en) * 1974-02-11 1976-10-26 Carnation Company Sunscreening method using rice bran oil
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS5587793A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Carcinostatic meso-tetra(p-carboxyphenyl)porphine derivative
JPS5787793A (en) * 1980-11-19 1982-06-01 Mitsubishi Heavy Ind Ltd Hydraulic steering apparatus for vessel
US4386087A (en) * 1981-07-01 1983-05-31 Research Foundation Of The City University Of New York N-Substituted metalloporphyrins as anti-tumor agents against PS-P-388(P388) leukemia in animals
JPH0249315B2 (ja) * 1981-08-17 1990-10-29 Seisan Kaihatsu Kagaku Kenkyusho Sosuiseichikankiojusuruhorufuirinoyobisonosakutai
AU549719B2 (en) * 1981-09-08 1986-02-06 Metalaser Technologies Limited Photoradiation method and arrangement
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
AU5036785A (en) 1986-06-05
EP0186962A1 (de) 1986-07-09
AU578329B2 (en) 1988-10-20
EP0186962B1 (de) 1989-04-12
JPS61130220A (ja) 1986-06-18
IE852906L (en) 1986-05-26
DE3569332D1 (en) 1989-05-18
CA1257202A (en) 1989-07-11
ZA858986B (en) 1986-08-27
GB8429845D0 (en) 1985-01-03
JPH0653665B2 (ja) 1994-07-20
HK132493A (en) 1993-12-10
US4837221A (en) 1989-06-06
IE58500B1 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
ATE42037T1 (de) Porphyrine und krebsbehandlung.
DE10299012I1 (de) Porphyrine and Arzneimittel zur Krebsbehandlung
ITMI920528A1 (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
NO882785L (no) Heksacyklisk forbindelse.
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
DE3774918D1 (de) Cancerostatisches mittel.
ES502656A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
ES2033467T3 (es) Derivados de dehidrocolecalciferol.
SE7709001L (sv) Rifamycinforening och sett att framstella densamma
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
AU2525488A (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy
ATE23719T1 (de) Rifamycinderivate, herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ES2054987T3 (es) Hidroxi-1,2,3,4-tetrahidroaminoacridinas, un procedimiento para su preparacion y su uso como medicamentos.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE47863T1 (de) Makrolide derivate.
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno
SE7309193L (de)
JPS5649400A (en) Novel derivative of 99chloroprednisolone* manufacture thereof and medicine containing same for inflammation and bronchial allurgic disease treatment

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee